Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparison of oral versus vaginal misoprostol for medical management of early fetal demise at Akhtar Saeed Trust Hospital, Lahore.

View through CrossRef
Objective: To compare the efficacy, safety, and clinical outcomes of oral versus vaginal misoprostol for medical management of first-trimester missed abortion at Akhtar Saeed Trust Hospital, Lahore. Study Design: Randomized Controlled Trial. Setting: Akhtar Saeed Trust Hospital, Lahore. Period: 15 November 2024 to 15 February 2025. Methods: A total of 110 female patients aged 18–45 years with a confirmed diagnosis of first-trimester missed abortion (gestational age <14 weeks) were enrolled. Participants were randomly assigned into two groups: Group A received oral misoprostol (400μg every six hours, up to three doses), and Group B received vaginal misoprostol (400μg soaked in normal saline, every six hours, up to three doses). Primary outcomes included treatment efficacy (complete uterine evacuation within 24 hours) and the need for surgical evacuation. Secondary outcomes included the mean time to expulsion and adverse effects such as bleeding, pain, vomiting, fever, and diarrhea. Data were analyzed using SPSS version 25.0, with a chi-square test used to compare efficacy between groups. Results: The efficacy of vaginal misoprostol (93.1%) was significantly higher than oral misoprostol (75.0%) (p=0.009). The mean time to expulsion was shorter in the vaginal group (10.87±2.0 hours) compared to the oral group (13.24±2.0 hours). The need for surgical evacuation was significantly higher in the oral group (25.0%) than in the vaginal group (6.9%) (p=0.009). Adverse effects, including bleeding, abdominal pain, vomiting, fever, and diarrhea, were comparable between groups, with no statistically significant differences. Conclusion: Vaginal misoprostol is more effective, results in faster expulsion, and significantly reduces the need for surgical evacuation compared to oral misoprostol. Given its superior clinical outcomes, vaginal misoprostol should be considered the preferred method for the medical management of first-trimester missed abortion.
Title: Comparison of oral versus vaginal misoprostol for medical management of early fetal demise at Akhtar Saeed Trust Hospital, Lahore.
Description:
Objective: To compare the efficacy, safety, and clinical outcomes of oral versus vaginal misoprostol for medical management of first-trimester missed abortion at Akhtar Saeed Trust Hospital, Lahore.
Study Design: Randomized Controlled Trial.
Setting: Akhtar Saeed Trust Hospital, Lahore.
Period: 15 November 2024 to 15 February 2025.
Methods: A total of 110 female patients aged 18–45 years with a confirmed diagnosis of first-trimester missed abortion (gestational age <14 weeks) were enrolled.
Participants were randomly assigned into two groups: Group A received oral misoprostol (400μg every six hours, up to three doses), and Group B received vaginal misoprostol (400μg soaked in normal saline, every six hours, up to three doses).
Primary outcomes included treatment efficacy (complete uterine evacuation within 24 hours) and the need for surgical evacuation.
Secondary outcomes included the mean time to expulsion and adverse effects such as bleeding, pain, vomiting, fever, and diarrhea.
Data were analyzed using SPSS version 25.
0, with a chi-square test used to compare efficacy between groups.
Results: The efficacy of vaginal misoprostol (93.
1%) was significantly higher than oral misoprostol (75.
0%) (p=0.
009).
The mean time to expulsion was shorter in the vaginal group (10.
87±2.
0 hours) compared to the oral group (13.
24±2.
0 hours).
The need for surgical evacuation was significantly higher in the oral group (25.
0%) than in the vaginal group (6.
9%) (p=0.
009).
Adverse effects, including bleeding, abdominal pain, vomiting, fever, and diarrhea, were comparable between groups, with no statistically significant differences.
Conclusion: Vaginal misoprostol is more effective, results in faster expulsion, and significantly reduces the need for surgical evacuation compared to oral misoprostol.
Given its superior clinical outcomes, vaginal misoprostol should be considered the preferred method for the medical management of first-trimester missed abortion.

Related Results

Potentially acute misoprostol toxicity during third-trimester pregnancy: a case report
Potentially acute misoprostol toxicity during third-trimester pregnancy: a case report
Background: The International Federation of Gynecology and Obstetrics (FIGO) recommends the dosage of misoprostol for pregnancy termination in >28 weeks is 25 mcg to 100 mcg per...
Efficacy of oral versus vaginal misoprostol in the management of first trimester incomplete miscarriage.
Efficacy of oral versus vaginal misoprostol in the management of first trimester incomplete miscarriage.
Objective: To compare the efficacy of oral versus vaginal misoprostol in first trimester incomplete miscarriage. Study Design: Cross-sectional study. Setting: Gynae B Unit of Lady ...
A comparative study of 25 mcg vs 50 mcg of vaginal misoprostol for induction of labour
A comparative study of 25 mcg vs 50 mcg of vaginal misoprostol for induction of labour
Background: The objectives of the current study were to compare the efficacy and safety of 25μg and 50μg of intravaginal misoprostol for induction of labor at term and to study the...
Efficacy of Vaginal Misoprostol and Intracervical Catheterization in Labour Induction for Vaginal Delivery in Eclampsia Patients
Efficacy of Vaginal Misoprostol and Intracervical Catheterization in Labour Induction for Vaginal Delivery in Eclampsia Patients
Background: Eclampsia, a severe complication of pregnancy characterized by seizures, remains a significant cause of maternal and neonatal morbidity and mortality. Effective and saf...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Misoprostol for non-alcoholic steatohepatitis: a randomised control trial
Misoprostol for non-alcoholic steatohepatitis: a randomised control trial
Introduction The management of non-alcoholic steatohepatitis (NASH) is an unmet clinical need. Misoprostol, a structural analogue of naturally occurring prostagla...

Back to Top